These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26467148)

  • 21. Likelihood ratio tests for a dose-response effect using multiple nonlinear regression models.
    Gutjahr G; Bornkamp B
    Biometrics; 2017 Mar; 73(1):197-205. PubMed ID: 27399200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the role of Baseline measurements for crossover designs under the self and mixed carryover effects model.
    Liang Y; Carriere KC
    Biometrics; 2010 Mar; 66(1):140-8. PubMed ID: 19432775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimax D-optimal designs for the logistic model.
    King J; Wong WK
    Biometrics; 2000 Dec; 56(4):1263-7. PubMed ID: 11129489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal designs for estimating the interesting part of a dose-effect curve.
    Miller F; Guilbaud O; Dette H
    J Biopharm Stat; 2007; 17(6):1097-115. PubMed ID: 18027219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-finding designs: the role of convergence properties.
    Oron AP; Azriel D; Hoff PD
    Int J Biostat; 2011 Oct; 7():Article 39. PubMed ID: 22718676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical trials.
    Bornkamp B
    Biom J; 2014 Nov; 56(6):947-62. PubMed ID: 24984691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fitting Emax models to clinical trial dose-response data when the high dose asymptote is ill defined.
    Brain P; Kirby S; Larionov R
    Pharm Stat; 2014; 13(6):364-70. PubMed ID: 25228394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust and efficient design of experiments for the Monod model.
    Dette H; Melas VB; Pepelyshev A; Strigul N
    J Theor Biol; 2005 Jun; 234(4):537-50. PubMed ID: 15808874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyzing multi-response data using forcing functions.
    Zhang L; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):283-305. PubMed ID: 16283535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression analysis of panel count data with dependent observation times.
    Sun J; Tong X; He X
    Biometrics; 2007 Dec; 63(4):1053-9. PubMed ID: 18078478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical considerations for optimal designs in clinical dose finding studies.
    Bretz F; Dette H; Pinheiro JC
    Stat Med; 2010 Mar; 29(7-8):731-42. PubMed ID: 20213708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Random walk designs for selecting pool sizes in group testing estimation with small samples.
    Haber G; Malinovsky Y
    Biom J; 2017 Nov; 59(6):1382-1398. PubMed ID: 28792074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.
    Ette EI; Kelman AW; Howie CA; Whiting B
    Ann Pharmacother; 1993 Sep; 27(9):1034-9. PubMed ID: 8117353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of confounding factors on designs for dose-effect relationship estimates.
    Girard P; Laporte-Simitsidis S; Mismetti P; Decousus H; Boissel JP
    Stat Med; 1995 May 15-30; 14(9-10):987-1005; discussion 1007-8. PubMed ID: 7569515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-Objective Optimal Designs for Studying the Dose Response Function and Interesting Dose Levels.
    Hyun SW; Wong WK
    Int J Biostat; 2015 Nov; 11(2):253-71. PubMed ID: 26565557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast precision estimation in high-dimensional multivariate joint models.
    Nassiri V; Ivanova A; Molenberghs G; Verbeke G
    Biom J; 2017 Nov; 59(6):1221-1231. PubMed ID: 28620935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferences on the association parameter in copula models for bivariate survival data.
    Shih JH; Louis TA
    Biometrics; 1995 Dec; 51(4):1384-99. PubMed ID: 8589230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance subsampling designs for comparative research: estimation and optimal planning.
    Frangakis CE; Baker SG
    Biometrics; 2001 Sep; 57(3):899-908. PubMed ID: 11550943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.